AI-Squared Management’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-18,975
Closed -$1.38M 27
2024
Q1
$1.38M Buy
+18,975
New +$1.58M 1.04% 14

Other funds holding LABD

AI-Squared Management's LABD Position: Q2 2024 in Review

AI-Squared Management sold out of Direxion Daily S&P Biotech Bear 3X ETF (LABD) in Q2 2024, closing a stake of 18,975 shares — an estimated $1.38M sold.

AI-Squared Management first reported a position in LABD in Q1 2024 and held it in 1 quarter. The position peaked at $1.38M in Q1 2024. 17 funds tracked by Wall St. Rank hold LABD as of Q2 2024.

  • AI-Squared Management reported no remaining Direxion Daily S&P Biotech Bear 3X ETF position as of Q2 2024 after selling out during the quarter.
  • AI-Squared Management sold 18,975 Direxion Daily S&P Biotech Bear 3X ETF shares in Q2 2024, an estimated $1.38M.
  • AI-Squared Management first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q1 2024 and held it in 1 quarter.
  • AI-Squared Management's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $1.38M in Q1 2024.
  • 17 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q2 2024.

Based on AI-Squared Management's 13F filing for Q2 2024, filed 9 Aug 2024.